Codexis Inc (NASDAQ: CDXS) kicked off on Tuesday, down -8.47% from the previous trading day, before settling in for the closing price of $3.07. Over the past 52 weeks, CDXS has traded in a range of $1.90-$6.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -33.31%. While this was happening, its average annual earnings per share was recorded 22.15%. With a float of $80.17 million, this company’s outstanding shares have now reached $82.84 million.
Let’s determine the extent of company efficiency that accounts for 188 employees. In terms of profitability, gross margin is 69.08%, operating margin of -134.4%, and the pretax margin is -149.4%.
Codexis Inc (CDXS) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Codexis Inc is 3.23%, while institutional ownership is 82.81%. The most recent insider transaction that took place on Jun 27 ’25, was worth 239,000. In this transaction 10% Owner of this company bought 100,000 shares at a rate of $2.39, taking the stock ownership to the 12,350,000 shares. Before that another transaction happened on Jun 12 ’25, when Company’s 10% Owner bought 100,000 for $2.25, making the entire transaction worth $225,000. This insider now owns 12,100,000 shares in total.
Codexis Inc (CDXS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 22.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.30% during the next five years compared to -33.31% drop over the previous five years of trading.
Codexis Inc (NASDAQ: CDXS) Trading Performance Indicators
Take a look at Codexis Inc’s (CDXS) current performance indicators. Last quarter, stock had a quick ratio of 3.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.99, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Codexis Inc (CDXS)
Looking closely at Codexis Inc (NASDAQ: CDXS), its last 5-days average volume was 0.97 million, which is a jump from its year-to-date volume of 0.87 million. As of the previous 9 days, the stock’s Stochastic %D was 73.28%.
During the past 100 days, Codexis Inc’s (CDXS) raw stochastic average was set at 35.55%, which indicates a significant decrease from 59.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was higher than the 0.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.48, while its 200-day Moving Average is $3.41. However, in the short run, Codexis Inc’s stock first resistance to watch stands at $3.03. Second resistance stands at $3.25. The third major resistance level sits at $3.38. If the price goes on to break the first support level at $2.68, it is likely to go to the next support level at $2.55. Now, if the price goes above the second support level, the third support stands at $2.33.
Codexis Inc (NASDAQ: CDXS) Key Stats
The company with the Market Capitalisation of 232.79 million has total of 82,845K Shares Outstanding. Its annual sales at the moment are 59,350 K in contrast with the sum of -65,280 K annual income. Company’s last quarter sales were recorded 7,540 K and last quarter income was -20,690 K.
